Updated July 1st, 2026
METHYLPREDNISOLONE ACETATE J Code: J1010
Injection, methylprednisolone acetate, 1 mg
Q4 2026 Medicare Payment Limit for J1010, effective October 1, 2026: $0.123 per HCPCS billing unit, up 5.1% from $0.117. From CMS's final file.
Q4 2026 Final ?
$0.123 5.1%
Medicare Payment Limit ?
$0.117
/ HCPCS billing unit · Q3 2026 APC Payment Limit ?
Not published
CMS publishes none for Q3 2026 Drug & Product Overview
HCPCS Descriptor Injection, methylprednisolone acetate, 1 mg
HCPCS Added Date April 1, 2024
Manufacturer Multiple Manufacturers
Route of Administration Intra-Arterial, Intra-Articular, Intralesional, Intrameningeal, Intramuscular, Intrasynovial, Soft Tissue
Generic Status Multi-Source; Generic
Dosage Type Single-Dose, Multi-Dose
Dosage Form Injection, Suspension
About METHYLPREDNISOLONE ACETATE
Methylprednisolone Acetate is a medication aligned to the HCPCS J Code: J1010 for billing, pricing, and reimbursement purposes in the United States. Classified under Misc., it is administered via the intra-arterial, intra-articular, intralesional, intrameningeal, intramuscular, intrasynovial, or soft tissue routes and manufactured by multiple companies.
According to CMS Drug Use Information: Methylprednisolone is used to treat pain and swelling that occurs with arthritis and other joint disorders. This medication may also be used to treat various conditions such as blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/intestinal/kidney/lung diseases, and immune system disorders. It decreases your immune system's response to these conditions and reduces symptoms such as swelling, pain, and allergic-type reactions. Talk to your doctor about the risks and benefits of methylprednisolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Methylprednisolone is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. Showing 5 of 43 NDCs — log in for the full crosswalk.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 00009-0274-01 | Depo-Medrol | Pharmacia & Upjohn Company LLC | 100 | 100 MG / 5 ML |
| 00781-3516-75 | Methylprednisolone Acetate | Sandoz Inc. | 400 | 400 MG / 5 ML |
| 25021-0820-05 | methylprednisolone acetate | Sagent Pharmaceuticals | 200 | 200 MG / 5 ML |
| 42023-0238-01 | Methylprednisolone Acetate | Endo USA, Inc. | 200 | 200 MG / 5 ML |
| 50090-0436-00 | Depo-Medrol | A-S Medication Solutions | 80 | 80 MG / 1 ML |
| •••••-••••-•• Log in to view | METHYLPREDNISOLONE ACETATE | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | METHYLPREDNISOLONE ACETATE | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | METHYLPREDNISOLONE ACETATE | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
Login to view 38 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login → METHYLPREDNISOLONE ACETATE Pricing & Reimbursement
J1010 Private Payer Reimbursement
$0.12 / HCPCS unit as of Jan 2026
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →
Historical Graphing and Billing Calculator
Estimated reimbursement ASP × 100 units × 1 dose
— / administration
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →Methylprednisolone Acetate 505(b)(2) Information:
| HCPCS Code | Manufacturer | Active Ingredient | HCPCS Description |
|---|---|---|---|
| J1010 | Generic Code (Multiple Manufacturers) | Methylprednisolone Acetate | Injection, methylprednisolone acetate, 1 mg |
METHYLPREDNISOLONE ACETATE CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular |
Not on the CMS JW / JZ list
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
METHYLPREDNISOLONE ACETATE Medically Unlikely Edits (MUE)
The most billing units of J1010 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.
Practitioner Office & Hospital Outpatient
160 units / day
= 160 mg per day
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
METHYLPREDNISOLONE ACETATE Clinical Information
Indications and drug classification.
Treated Diseases & Conditions
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Acquired (autoimmune) hemolytic anemia Acute Gouty Arthritis Acute Severe Dermatitis due to Poison Ivy Acute bursitis Acute gouty arthritis Acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis Acute nonspecific tenosynovitis Acute rheumatic carditis Acute severe dermatitis due to poison ivy Adrenogenital Syndrome Adrenogenital syndrome Allergic States (asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions) Allergic States (severe or incapacitating) Allergic conditions (asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions) Allergic conditions (severe or incapacitating) Allergic conditions (severe/incapacitating) — systemic IM Allergic states (asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions) Alopecia Areata Alopecia areata Ankylosing spondylitis Asthma Atopic dermatitis Berylliosis Bullous dermatitis herpetiformis Bursitis Bursitis (acute and subacute) Bursitis, tendinitis, tenosynovitis, epicondylitis, ganglia (cystic tumors of an aponeurosis or tendon) Bursitis, tenosynovitis, tendinitis, epicondylitis, and ganglia Bursitis, tenosynovitis, tendinitis, epicondylitis, ganglion (tendinous or bursal structures) Cerebral Edema Cerebral Edema associated with primary or metastatic brain tumor or craniotomy Cerebral edema associated with primary or metastatic brain tumor or craniotomy Chronic Contact Dermatitis Chronic contact dermatitis Conditions requiring systemic corticosteroid therapy Conditions requiring systemic corticosteroid therapy (prolonged effect) Conditions requiring systemic corticosteroid therapy (temporary substitute for oral therapy) Congenital adrenal hyperplasia Congenital adrenal hyperplasia (adrenogenital syndrome) Congenital hypoplastic anemia (Diamond Blackfan anemia) Cystic Tumors of Aponeurosis or Tendon (Ganglia) Cystic tumors of an aponeurosis or tendon (ganglia) Cystic tumors of aponeurosis or tendon (ganglia) Dermatologic Conditions (intralesional) Dermatologic Diseases (bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme) Dermatologic Diseases (systemic IM, general) Dermatologic Lesions (alopecia areata, discoid lupus erythematosus, keloids, granuloma annulare, lichen planus, lichen simplex chronicus, psoriatic plaques, necrobiosis lipoidica diabeticorum) Dermatologic Lesions (systemic IM) Dermatologic Lesions (systemic corticoid therapy) Dermatologic Lesions (systemic) Dermatologic Lesions benefited by systemic corticoid therapy Dermatologic conditions (alopecia areata, discoid lupus erythematosus, keloids, granuloma annulare, lichen planus, lichen simplex chronicus, psoriatic plaques, necrobiosis lipoidica diabeticorum) Dermatologic conditions (intralesional) Dermatologic conditions (local intralesional) Dermatologic conditions (local) Dermatologic diseases (bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis fungoides, pemphigus, severe erythema multiforme) Dermatologic diseases (bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme) Dermatologic diseases (systemic corticoid therapy) Dermatologic lesions Dermatologic lesions (alopecia areata, discoid lupus erythematosus, keloids, granuloma annulare, lichen planus, lichen simplex chronicus, psoriatic plaques, necrobiosis lipoidica diabeticorum) Dermatologic lesions (intralesional) Dermatologic lesions (systemic IM) Dermatologic lesions (systemic corticoid therapy) Dermatologic lesions (systemic) Dermatologic lesions benefited by systemic corticoid therapy Dermatologic lesions responsive to systemic corticoid therapy Dermatomyositis Discoid Lupus Erythematosus Discoid lupus erythematosus Endocrine Disorders Endocrine Disorders (adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis) Endocrine disorders (adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis) Endocrine disorders (adrenocortical insufficiency, hypercalcemia associated with cancer, nonsuppurative thyroiditis) Endocrine disorders (primary/secondary adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis) Epicondylitis Exfoliative dermatitis Fulminating or disseminated pulmonary tuberculosis Ganglion (cystic tumor of aponeurosis or tendon) Ganglion, Tendinitis, Epicondylitis Ganglion, tendinitis, epicondylitis Gastrointestinal Diseases Gastrointestinal Diseases (regional enteritis, ulcerative colitis) Gastrointestinal diseases (regional enteritis, ulcerative colitis) Granuloma Annulare Granuloma annulare Granuloma annulare, lichen planus, lichen simplex chronicus, psoriatic plaques, necrobiosis lipoidica diabeticorum (localized hypertrophic inflammatory lesions) Hematologic Disorders Hematologic Disorders (autoimmune hemolytic anemia, Diamond Blackfan anemia, pure red cell aplasia, secondary thrombocytopenia) Hematologic disorders (autoimmune hemolytic anemia, Diamond Blackfan anemia, pure red cell aplasia, secondary thrombocytopenia) Hypercalcemia associated with cancer Idiopathic eosinophilic pneumonias Idiopathic nephrotic syndrome Idiopathic nephrotic syndrome or nephrotic syndrome due to lupus erythematosus Keloids Leukemias and Lymphomas Leukemias and lymphomas Lichen Planus Lichen Simplex Chronicus (Neurodermatitis) Lichen planus Lichen simplex chronicus (neurodermatitis) Multiple Indications (IM systemic — general) Multiple Indications (IM systemic — oral substitute weekly) Multiple Indications (IM systemic — oral substitute) Multiple Indications (IM systemic — pediatric) Multiple Indications (systemic IM — general) Multiple indications (general systemic IM use) Multiple indications (systemic IM therapy) — general Multiple indications (systemic IM therapy) — pediatric Multiple indications — systemic IM (general) Multiple systemic conditions (general IM use) Mycosis fungoides Necrobiosis Lipoidica Diabeticorum Necrobiosis lipoidica diabeticorum Neoplastic Diseases (leukemias and lymphomas) Neoplastic diseases (leukemias and lymphomas) Nephrotic syndrome due to lupus erythematosus Nonsuppurative thyroiditis Ocular inflammatory conditions unresponsive to topical corticosteroids Ophthalmic Diseases Ophthalmic Diseases (sympathetic ophthalmia, temporal arteritis, uveitis, ocular inflammatory conditions) Ophthalmic diseases (sympathetic ophthalmia, temporal arteritis, uveitis, ocular inflammatory conditions) Osteoarthritis Osteoarthritis (synovitis of osteoarthritis) Pediatric patients — general systemic indications Pemphigus Polymyositis Primary or secondary adrenocortical insufficiency Psoriatic Plaques Psoriatic arthritis Psoriatic plaques Pure red cell aplasia Regional enteritis Regional enteritis and ulcerative colitis Renal Diseases (idiopathic nephrotic syndrome, lupus erythematosus nephrotic syndrome) Renal Diseases (nephrotic syndrome) Renal diseases (idiopathic nephrotic syndrome, lupus erythematosus nephrotic syndrome) Respiratory Diseases Respiratory Diseases (berylliosis, pulmonary tuberculosis, idiopathic eosinophilic pneumonias, sarcoidosis) Respiratory diseases (berylliosis, pulmonary tuberculosis, idiopathic eosinophilic pneumonias, sarcoidosis) Respiratory diseases (berylliosis, pulmonary tuberculosis, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis) Rheumatic Disorders Rheumatic Disorders (acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, dermatomyositis, polymyositis, systemic lupus erythematosus) Rheumatic disorders (acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, dermatomyositis, polymyositis, systemic lupus erythematosus) Rheumatoid Arthritis Rheumatoid Arthritis (systemic IM maintenance) Rheumatoid Arthritis and Osteoarthritis Rheumatoid arthritis Rheumatoid arthritis (systemic IM) Rheumatoid arthritis (systemic) Rheumatoid arthritis and osteoarthritis Seborrheic Dermatitis Seborrheic dermatitis Secondary thrombocytopenia Severe erythema multiforme (Stevens-Johnson syndrome) Subacute bursitis Sympathetic ophthalmia Symptomatic sarcoidosis Synovitis of osteoarthritis Systemic conditions (general IM use) Systemic corticosteroid-responsive conditions Systemic corticosteroid-responsive conditions (allergic states, dermatologic, endocrine, gastrointestinal, hematologic, neoplastic, nervous system, ophthalmic, renal, respiratory and rheumatic disorders) Systemic corticosteroid-responsive conditions (temporary substitute for oral therapy) Systemic lupus erythematosus Temporal arteritis Tendinitis Tendinitis, Tenosynovitis, Epicondylitis, Ganglion Tendinitis, tenosynovitis, epicondylitis, ganglion Tendinitis, tenosynovitis, epicondylitis, ganglion of tendon sheath Tenosynovitis Tenosynovitis / Tendinitis Trichinosis with neurologic or myocardial involvement Tuberculous Meningitis with subarachnoid block Tuberculous meningitis with subarachnoid block Ulcerative colitis Uveitis Various Indications (pediatric patients) dental and oral surgery anesthesia dental and oral surgery procedures local or regional anesthesia or analgesia obstetrical procedures
No conditions match your search.
Drug Class
Corticosteroid Hormone Receptor Agonists [MoA]Corticosteroid [EPC]
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is a Methylprednisolone Acetate billing and coding guide available?
We have not yet identified a manufacturer source of billing and coding information for Methylprednisolone Acetate
Is Methylprednisolone Acetate patient assistance information available?
Our team did not identify a source for Methylprednisolone Acetate patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Methylprednisolone Acetate prescribing information?
Our team is still working to identify a source of prescribing information for METHYLPREDNISOLONE ACETATE
Where can I find Methylprednisolone Acetate side effect information?
Our team has not yet identified a source of side effect information for METHYLPREDNISOLONE ACETATE
Does billing METHYLPREDNISOLONE ACETATE require JZ/JW wastage modifiers?
CMS does not include METHYLPREDNISOLONE ACETATE (J1010) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1010. For more information, visit the link below.
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to METHYLPREDNISOLONE ACETATE.
J1020DEPO-MEDROLInjection, methylprednisolone acetate, 20 mgPfizer·Added January 1, 1982J1030DEPO-MEDROLInjection, methylprednisolone acetate, 40 mgMultiple Manufacturers·Added January 1, 1982J1040DEPO-MEDROLInjection, methylprednisolone acetate, 80 mgMultiple Manufacturers·Added January 1, 1982J2919METHYLPREDNISOLONE SODIUM SUCCINATEInjection, methylprednisolone sodium succinate, 5 mgMultiple Manufacturers·Added April 1, 2024J1100Dexamethasone Sodium PhosphateInjection, dexamethasone sodium phosphate, 1 mgMultiple Manufacturers·Added January 1, 1982J3300TRIESENCEInjection, triamcinolone acetonide (triesence), preservative free, 1 mgHarrow Eye·Added January 1, 2009J3301KENALOG-10Injection, triamcinolone acetonide, not otherwise specified, 10 mgMultiple Manufacturers·Added January 1, 1991J7509MEDROLMethylprednisolone oral, per 4 mgMultiple Manufacturers·Added January 1, 1996J7510PREDNISOLONEPrednisolone oral, per 5 mgMultiple Manufacturers·Added January 1, 1996J7512PrednisonePrednisone, immediate release or delayed release, oral, 1 mgMultiple Manufacturers·Added January 1, 2016
